| Cancer Type |
|
|
|
|
Breast |
6 |
(9, 23, 24, 27, 32, 37) |
|
Lymphoma |
5 |
(11–13, 26, 28) |
|
Anogenital |
5 |
(15, 17, 20, 25, 34) |
|
Colon and Rectum |
4 |
(18, 29, 30, 38) |
|
Pancreas |
4 |
(8, 21, 35, 36) |
|
Liver |
3 |
(19, 22, 33) |
|
Oropharynx |
2 |
(14, 31) |
|
Lung, Prostate |
2 |
(10, 16 [respectively]) |
| Biospecimen |
|
|
|
|
FFPE Tissues Other Than Arrays |
19 |
(10–17, 19, 20, 23, 25, 27, 29–31, 34, 37, 38) |
|
Tissue Microarray/Multiple Tumor Arrays |
11 |
(8, 9, 18, 21, 22, 24, 26, 28, 32, 35, 36) |
| Biomarker |
|
|
|
|
Immunohistochemical Staining |
10 |
(8, 9, 18, 21–23, 30, 32, 35, 36) |
|
Genetic Sequences |
15 |
(10–17, 19, 20, 26, 28, 29, 31, 34) |
|
Histopathology Markers |
4 |
(24, 25, 27, 37) |
|
DNA Methylation |
2 |
(33, 38) |
| Demographics |
|
|
|
|
Racial and Ethnic Distribution |
15 |
(9, 12–14, 17, 18, 20–22, 24, 26, 35–38) |
|
Molecular Subtype Distribution |
7 |
(9, 11–13, 26, 28, 30) |
|
Trend Projection, Subtype Distribution |
2 |
(14, 15) |
